Humacyte, Inc. (NASDAQ:HUMA) Director Buys $14,998.70 in Stock
Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) Director Brady W. Dougan purchased 2,362 shares of the stock in a transaction dated Tuesday, June 4th. The stock was acquired at an average cost of $6.35 per share, with a total value of $14,998.70. Following the transaction, the director now directly owns 240,832 shares in the company, […]
More Stories
Otsuka Holdings Co., Ltd. (OTCMKTS:OTSKY) Sees Large Increase in Short Interest
Otsuka Holdings Co., Ltd. (OTCMKTS:OTSKY – Get Free Report) saw a significant growth in short interest in September. As of...
BTCS Inc. (NASDAQ:BTCS) Short Interest Update
BTCS Inc. (NASDAQ:BTCS – Get Free Report) was the target of a large decline in short interest in September. As...
CHS Inc. (NASDAQ:CHSCP) Sees Significant Growth in Short Interest
CHS Inc. (NASDAQ:CHSCP – Get Free Report) saw a significant increase in short interest in the month of September. As...
Pinnacle Bank (OTCMKTS:PBNK) Short Interest Update
Pinnacle Bank (OTCMKTS:PBNK – Get Free Report) was the target of a large decline in short interest in September. As...
Lantern Pharma Inc. (NASDAQ:LTRN) Short Interest Down 19.8% in September
Lantern Pharma Inc. (NASDAQ:LTRN – Get Free Report) saw a large decrease in short interest in September. As of September...
Mobico Group Plc (OTCMKTS:NXPGF) Sees Significant Decline in Short Interest
Mobico Group Plc (OTCMKTS:NXPGF – Get Free Report) saw a large drop in short interest in the month of September....